Biotech · Private company
Beijing Pearl Biotechnology Limited Liability Company
Track this companyFree. Adds Beijing Pearl Biotechnology Limited Liability Company to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ANS014004 + OsimertinibPhase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ANS014004 + PLB1004Phase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung CancerPHASE1_PHASE2 · NOT_YET_RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07285148 · fetched Nov 12, 2026